Lisa E. Baker

1.2k total citations
54 papers, 952 citations indexed

About

Lisa E. Baker is a scholar working on Cellular and Molecular Neuroscience, Clinical Psychology and Toxicology. According to data from OpenAlex, Lisa E. Baker has authored 54 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Cellular and Molecular Neuroscience, 23 papers in Clinical Psychology and 23 papers in Toxicology. Recurrent topics in Lisa E. Baker's work include Neurotransmitter Receptor Influence on Behavior (46 papers), Forensic Toxicology and Drug Analysis (23 papers) and Psychedelics and Drug Studies (22 papers). Lisa E. Baker is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (46 papers), Forensic Toxicology and Drug Analysis (23 papers) and Psychedelics and Drug Studies (22 papers). Lisa E. Baker collaborates with scholars based in United States, United Kingdom and Bulgaria. Lisa E. Baker's co-authors include Amy Goodwin, Alan Poling, J. B. Appel, Michele Taylor, J Panos, Kjell Svensson, Bryan A. Killinger, Adam J. Prus, Amanda J. Quisenberry and Tom Byrne and has published in prestigious journals such as Brain Research, Journal of Pharmacology and Experimental Therapeutics and Psychopharmacology.

In The Last Decade

Lisa E. Baker

53 papers receiving 924 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa E. Baker United States 18 755 384 372 259 102 54 952
Eric B. Thorndike United States 19 822 1.1× 502 1.3× 307 0.8× 294 1.1× 44 0.4× 35 1.2k
Georgetta Vosmer United States 16 1.2k 1.5× 504 1.3× 339 0.9× 238 0.9× 82 0.8× 23 1.4k
Viviane Hechler France 19 779 1.0× 537 1.4× 67 0.2× 220 0.8× 147 1.4× 24 1.0k
R.A. Rabin United States 21 1.2k 1.5× 115 0.3× 586 1.6× 524 2.0× 105 1.0× 51 1.5k
Kevin T. Finnegan United States 15 599 0.8× 139 0.4× 108 0.3× 226 0.9× 69 0.7× 21 775
Harry W. Broening United States 14 1.0k 1.4× 385 1.0× 183 0.5× 276 1.1× 92 0.9× 20 1.3k
Robert M. Virus United States 12 632 0.8× 251 0.7× 185 0.5× 208 0.8× 122 1.2× 18 1.1k
Annis O. Mechan United Kingdom 12 1.0k 1.4× 1.1k 2.9× 799 2.1× 121 0.5× 71 0.7× 13 1.6k
S. Stevens Negus United States 21 1.1k 1.4× 128 0.3× 95 0.3× 737 2.8× 377 3.7× 35 1.3k
Rómeó D. Andó Hungary 15 305 0.4× 111 0.3× 109 0.3× 146 0.6× 76 0.7× 28 730

Countries citing papers authored by Lisa E. Baker

Since Specialization
Citations

This map shows the geographic impact of Lisa E. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa E. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa E. Baker more than expected).

Fields of papers citing papers by Lisa E. Baker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa E. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa E. Baker. The network helps show where Lisa E. Baker may publish in the future.

Co-authorship network of co-authors of Lisa E. Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa E. Baker. A scholar is included among the top collaborators of Lisa E. Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa E. Baker. Lisa E. Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walther, Donna, et al.. (2024). Novel Benzofuran Derivatives Induce Monoamine Release and Substitute for the Discriminative Stimulus Effects of 3,4-Methylenedioxymethamphetamine. Journal of Pharmacology and Experimental Therapeutics. 391(1). 22–29.
2.
Baker, Lisa E., et al.. (2020). Conditioned place preference following concurrent treatment with 3, 4-methylenedioxypyrovalerone (MDPV) and methamphetamine in male and female Sprague-Dawley rats. Pharmacology Biochemistry and Behavior. 198. 173032–173032. 13 indexed citations
3.
4.
5.
Baker, Lisa E.. (2017). Hallucinogens in Drug Discrimination. Current topics in behavioral neurosciences. 36. 201–219. 12 indexed citations
6.
Baker, Lisa E., et al.. (2017). Evaluation of training dose in male Sprague-Dawley rats trained to discriminate 4-methylmethcathinone. Psychopharmacology. 234(21). 3271–3278. 11 indexed citations
7.
Perrine, Shane A., et al.. (2017). Repeated exposure to 3,4-methylenedioxypyrovalerone and cocaine produces locomotor sensitization with minimal effects on brain monoamines. Neuropharmacology. 134(Pt A). 22–27. 17 indexed citations
8.
Walters, Jennifer L., Theresa A. Lansdell, Keith J. Lookingland, & Lisa E. Baker. (2015). The effects of gestational and chronic atrazine exposure on motor behaviors and striatal dopamine in male Sprague-Dawley rats. Toxicology and Applied Pharmacology. 289(2). 185–192. 27 indexed citations
9.
Quisenberry, Amanda J. & Lisa E. Baker. (2015). Dopaminergic mediation of the discriminative stimulus functions of modafinil in rats. Psychopharmacology. 232(24). 4411–4419. 4 indexed citations
10.
Baker, Lisa E., H. Ross Payne, Ina Mexhitaj, et al.. (2014). Methamphetamine Induces Low Levels of Neurogenesis in Striatal Neuron Subpopulations and Differential Motor Performance. Neurotoxicity Research. 26(2). 115–129. 11 indexed citations
11.
Baker, Lisa E., et al.. (2014). Behavioral sensitization following concurrent exposure to mephedrone and D-amphetamine in female mice. Behavioural Pharmacology. 26(1 and 2 - Special Issue). 180–183. 15 indexed citations
12.
Mexhitaj, Ina, et al.. (2013). The role of the neuropeptide somatostatin on methamphetamine and glutamate-induced neurotoxicity in the striatum of mice. Brain Research. 1510. 38–47. 12 indexed citations
13.
Panos, J & Lisa E. Baker. (2011). Modulatory effects of low-dose MDMA on cocaine-induced locomotor activity and place conditioning in rats. Pharmacology Biochemistry and Behavior. 100(3). 377–381. 3 indexed citations
14.
Baker, Lisa E., et al.. (2009). Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats. Psychopharmacology. 203(2). 203–211. 41 indexed citations
15.
Baker, Lisa E., et al.. (2005). Discriminative stimulus effects of gamma-hydroxybutyrate (GHB) and its metabolic precursor, gamma-butyrolactone (GBL) in rats. Psychopharmacology. 181(3). 458–466. 15 indexed citations
16.
Goodwin, Amy & Lisa E. Baker. (2002). An analysis of the utility of differential outcome procedures in drug discrimination research. Behavioural Pharmacology. 13(4). 271–278. 5 indexed citations
17.
Goodwin, Amy, et al.. (2001). Antagonism of the discriminative stimulus effects of (+)-7-OH-DPAT by remoxipride but not PNU-99194A. Pharmacology Biochemistry and Behavior. 68(3). 371–377. 18 indexed citations
18.
Goudie, Andrew J., Lisa E. Baker, Judith A. Smith, et al.. (2001). Common discriminative stimulus properties in rats of muscarinic antagonists, clozapine and the D 3 preferring antagonist PNU-99194A: an analysis of possible mechanisms. Behavioural Pharmacology. 12(5). 303–315. 17 indexed citations
19.
Baker, Lisa E. & Malath Makhay. (1996). Effects of (+)-fenfluramine on 3,4-methylenedioxymethamphetamine (MDMA) discrimination in rats. Pharmacology Biochemistry and Behavior. 53(2). 455–461. 15 indexed citations
20.
Appel, James B., et al.. (1991). Use of Drug Discrimination in Drug Abuse Research. PsycEXTRA Dataset. 369–97. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric B. Thorndike Breakdown of academic impact, for papers by Georgetta Vosmer Breakdown of academic impact, for papers by Viviane Hechler Breakdown of academic impact, for papers by R.A. Rabin Breakdown of academic impact, for papers by Kevin T. Finnegan Breakdown of academic impact, for papers by Harry W. Broening Breakdown of academic impact, for papers by Robert M. Virus Breakdown of academic impact, for papers by Annis O. Mechan Breakdown of academic impact, for papers by S. Stevens Negus Breakdown of academic impact, for papers by Rómeó D. Andó
Rankless by CCL
2026